These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8648102)
21. Bacterial superantigens induce rapid and T cell receptor V beta-selective down-regulation of L-selectin (gp90Mel-14) in vivo. Miethke T; Wahl C; Holzmann B; Heeg K; Wagner H J Immunol; 1993 Dec; 151(12):6777-82. PubMed ID: 7505015 [TBL] [Abstract][Full Text] [Related]
22. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926 [TBL] [Abstract][Full Text] [Related]
23. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection. Chervonsky AV; Golovkina TV; Ross SR; Janeway CA J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520 [TBL] [Abstract][Full Text] [Related]
24. Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes. Matsuzawa A; Yasuda T; Sakamoto S; Nagase H; Nakano H; Yoshimoto T Scand J Immunol; 2001 Jun; 53(6):553-62. PubMed ID: 11422903 [TBL] [Abstract][Full Text] [Related]
25. Physiologic expression of two superantigens in the BDF1 mouse. Gollob KJ; Palmer E J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891 [TBL] [Abstract][Full Text] [Related]
26. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice. Papiernik M; Pontoux C; Golstein P Eur J Immunol; 1995 Jun; 25(6):1517-23. PubMed ID: 7542196 [TBL] [Abstract][Full Text] [Related]
27. The viral superantigen Mls-1a induces interferon-gamma secretion by specifically primed CD8+ cells but fails to trigger cytotoxicity. Herrmann T; Waanders GA; Chvatchko Y; MacDonald HR Eur J Immunol; 1992 Nov; 22(11):2789-93. PubMed ID: 1330577 [TBL] [Abstract][Full Text] [Related]
28. Distribution of cycling T lymphocytes in blood and lymphoid organs during immune responses. Vasseur F; Le Campion A; Pavlovitch JH; Pénit C J Immunol; 1999 May; 162(9):5164-72. PubMed ID: 10227988 [TBL] [Abstract][Full Text] [Related]
29. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus. Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410 [TBL] [Abstract][Full Text] [Related]
30. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341 [TBL] [Abstract][Full Text] [Related]
31. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses. Palmer LD; Saha B; Hodes RJ; Abe R J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899 [TBL] [Abstract][Full Text] [Related]
32. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells. McMahon CW; Bogatzki LY; Pullen AM Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822 [TBL] [Abstract][Full Text] [Related]
33. A stimulatory Mls-1 superantigen is destroyed by ultraviolet light while other Mtv-7 antigens remain intact. Significance for Mls-1 unresponsiveness. Dannecker G; Mecheri S; Clarke K; Dudhane A; Wang ZQ; Hoffmann MK J Immunol; 1992 Dec; 149(11):3463-7. PubMed ID: 1331237 [TBL] [Abstract][Full Text] [Related]
34. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. Golovkina TV; Dudley JP; Ross SR J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233 [TBL] [Abstract][Full Text] [Related]
35. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells. George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892 [TBL] [Abstract][Full Text] [Related]
36. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro. Hsu LJ; Jan MS; Lin YS Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973 [TBL] [Abstract][Full Text] [Related]
37. The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern. Andersson M; Acha-Orbea H Immunology; 1994 Nov; 83(3):438-43. PubMed ID: 7835968 [TBL] [Abstract][Full Text] [Related]
38. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire. Kilgannon P; Novak Z; Fotedar A; Singh B Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850 [TBL] [Abstract][Full Text] [Related]
39. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892 [TBL] [Abstract][Full Text] [Related]
40. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes. Tenorio EP; Saavedra R Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]